GlassScriptPhysician profile
Alok Goyal
NPI 1487634036
$7,406.55
in general payments reported to CMS, 2019-2025
65 companies · $900 in 2025
The $900 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,260 · 2020: $358 · 2021: $1,098 · 2022: $1,303 · 2023: $1,416 · 2024: $1,073 · 2025: $900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,289 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,288.68 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,203.82 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $773.76 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $569.88 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $430.08 | 2022-2025 | Rexulti, Nuedexta, Abilify Maintena |
| Astellas Pharma US INC | $379.00 | 2019-2024 | Veozah |
| Lilly USA, LLC | $346.72 | 2019-2025 | Kisunla, Amyvid, Mounjaro |
| Neurocrine Biosciences, INC. | $285.23 | 2021-2025 | Ingrezza |
| Nestle Healthcare Nutrition INC. | $241.22 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $234.45 | 2021-2025 | |
| Pfizer INC. | $231.11 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $215.87 | 2019-2024 | Gattex |
| Sunovion Pharmaceuticals INC. | $180.71 | 2019-2022 | |
| Gilead Sciences, INC. | $156.80 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $149.04 | 2022-2025 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.72 | 2019-2021 |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alok Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.